Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search Stock, IPO, MF
Open in App
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
Charts & Report
Charts and Graphs
Stock Report Pdf
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Natco Pharma Ltd.
NSE: NATCOPHARM
|
BSE: 524816
|
ISIN: INE987B01026
|
Industry: Pharmaceuticals
|
Mid-range Performer
821.5000
0.20
(
0.02
%)
NSE
Oct 05, 2026
15:31 PM
Near 52W Low of ₹785.60
Volume:
571.7K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Natco Pharma Ltd.
19 Mar 2025
821.50
0.02%
NATCO PHARMA
Hold:
Natco Pharma Ltd.
by
Geojit BNP Paribas
Target: 887
Target
Geojit BNP Paribas
Number of FII/FPI investors increased from 285 to 298 in Jun 2026 qtr.
More from Natco Pharma Ltd.
Recommended
IPO market shifts to listings after a busy September
|
05 Oct 2026, 06:18PM
Market closes higher, led by gains in banking and FMCG stocks
Trendlyne Marketwatch |
05 Oct 2026, 03:53PM
Earnings Call Transcript - Q4FY20 for Natco Pharma
|
18 Jun 2020